Quick Takeaways
- This page summarizes Jr. Robert E. Funck's Form 4 filing for ABBOTT LABORATORIES (ABT).
- 2 reported transactions and 0 derivative rows are listed below.
- Filing timestamp: 02 Mar 2023, 18:35.
Jr. Robert E. Funck - 28 Feb 2023 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)
- Signature
- /s/ Robert E. Funck, Jr. by Jessica H. Paik, Attorney-in-Fact
- Issuer symbol
- ABT
- Transactions as of
- 28 Feb 2023
- Net transactions value
- -$1,274,640
- Form type
- 4
- Filing time
- 02 Mar 2023, 18:35:15 UTC
- Previous filing
- 22 Feb 2023
- Next filing
- 15 Sep 2023
- SEC
- View on sec.gov
Quoteable Key Fact
"Jr. Robert E. Funck filed Form 4 for ABBOTT LABORATORIES (ABT) on 02 Mar 2023."
What Changed
- Previous filing in this sequence was filed on 22 Feb 2023.
- Current net transaction value: -$1,274,640.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ABT | Common shares without par value | Tax liability | $1,147,355 | -11,500 | -5% | $99.77 | 219,501 | 28 Feb 2023 | Direct | |
| transaction | ABT | Common shares without par value | Sale | $127,285 | -1,264 | -0.58% | $100.70 | 218,237 | 01 Mar 2023 | Direct | |
| holding | ABT | Common shares without par value | 10,000 | 28 Feb 2023 | By Trust | F1 | |||||
| holding | ABT | Common shares without par value | 10,000 | 28 Feb 2023 | By Trust | F1 | |||||
| holding | ABT | Common shares without par value | 18,405 | 28 Feb 2023 | Profit Sharing Trust | F2 | |||||
| holding | ABT | Common shares without par value | 500 | 28 Feb 2023 | By Daughter | F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Held in daughter's annual gift trust. The reporting person disclaims beneficial ownership of all securities held by the trust. |
| F2 | Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2023. |
| F3 | The reporting person disclaims beneficial ownership of all securities held by his daughter. |
Remarks:
The sale transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1(c).